Biohaven Pharmaceutical Stock Forecast - Naive Prediction
| BHVN Stock | USD 13.51 0.25 1.82% |
The Naive Prediction forecasted value of Biohaven Pharmaceutical Holding on the next trading day is expected to be 14.43 with a mean absolute deviation of 0.67 and the sum of the absolute errors of 40.96. Biohaven Stock Forecast is based on your current time horizon. Although Biohaven Pharmaceutical's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Biohaven Pharmaceutical's systematic risk associated with finding meaningful patterns of Biohaven Pharmaceutical fundamentals over time.
As of today the rsi of Biohaven Pharmaceutical's share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (1.49) | EPS Estimate Current Year (5.52) | EPS Estimate Next Year (2.88) | Wall Street Target Price 20.8 | EPS Estimate Current Quarter (1.61) |
Using Biohaven Pharmaceutical hype-based prediction, you can estimate the value of Biohaven Pharmaceutical Holding from the perspective of Biohaven Pharmaceutical response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Biohaven Pharmaceutical using Biohaven Pharmaceutical's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Biohaven using crowd psychology based on the activity and movement of Biohaven Pharmaceutical's stock price.
Biohaven Pharmaceutical Short Interest
An investor who is long Biohaven Pharmaceutical may also wish to track short interest. As short interest increases, investors should be becoming more worried about Biohaven Pharmaceutical and may potentially protect profits, hedge Biohaven Pharmaceutical with its derivative instruments, or be ready for some potential downside.
200 Day MA 14.5157 | Short Percent 0.1652 | Short Ratio 6.31 | Shares Short Prior Month 16.5 M | 50 Day MA 10.581 |
Biohaven Pharmaceutical Hype to Price Pattern
Investor biases related to Biohaven Pharmaceutical's public news can be used to forecast risks associated with an investment in Biohaven. The trend in average sentiment can be used to explain how an investor holding Biohaven can time the market purely based on public headlines and social activities around Biohaven Pharmaceutical Holding. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Biohaven Pharmaceutical Implied Volatility | 1.25 |
Biohaven Pharmaceutical's implied volatility exposes the market's sentiment of Biohaven Pharmaceutical Holding stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Biohaven Pharmaceutical's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Biohaven Pharmaceutical stock will not fluctuate a lot when Biohaven Pharmaceutical's options are near their expiration.
The Naive Prediction forecasted value of Biohaven Pharmaceutical Holding on the next trading day is expected to be 14.43 with a mean absolute deviation of 0.67 and the sum of the absolute errors of 40.96. Biohaven Pharmaceutical after-hype prediction price | USD 13.49 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Biohaven Pharmaceutical to cross-verify your projections. Prediction based on Rule 16 of the current Biohaven contract
Based on the Rule 16, the options market is currently suggesting that Biohaven Pharmaceutical Holding will have an average daily up or down price movement of about 0.0781% per day over the life of the 2026-04-17 option contract. With Biohaven Pharmaceutical trading at USD 13.51, that is roughly USD 0.0106 . If you think that the market is fully incorporating Biohaven Pharmaceutical's daily price movement you should consider acquiring Biohaven Pharmaceutical Holding options at the current volatility level of 1.25%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Biohaven Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Biohaven Pharmaceutical's spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Biohaven Pharmaceutical's options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Biohaven Pharmaceutical stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Biohaven Pharmaceutical's open interest, investors have to compare it to Biohaven Pharmaceutical's spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Biohaven Pharmaceutical is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Biohaven. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Biohaven Pharmaceutical Additional Predictive Modules
Most predictive techniques to examine Biohaven price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biohaven using various technical indicators. When you analyze Biohaven charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Biohaven Pharmaceutical Cash Forecast
Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Biohaven Pharmaceutical's financial statements to estimate their effects on upcoming price movements.
Cash | First Reported 2017-03-31 | Previous Quarter 165.8 M | Current Value 184.8 M | Quarterly Volatility 126.9 M |
Biohaven Pharmaceutical Naive Prediction Price Forecast For the 26th of January
Given 90 days horizon, the Naive Prediction forecasted value of Biohaven Pharmaceutical Holding on the next trading day is expected to be 14.43 with a mean absolute deviation of 0.67, mean absolute percentage error of 0.90, and the sum of the absolute errors of 40.96.Please note that although there have been many attempts to predict Biohaven Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Biohaven Pharmaceutical's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Biohaven Pharmaceutical Stock Forecast Pattern
| Backtest Biohaven Pharmaceutical | Biohaven Pharmaceutical Price Prediction | Buy or Sell Advice |
Biohaven Pharmaceutical Forecasted Value
In the context of forecasting Biohaven Pharmaceutical's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Biohaven Pharmaceutical's downside and upside margins for the forecasting period are 6.73 and 22.13, respectively. We have considered Biohaven Pharmaceutical's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Biohaven Pharmaceutical stock data series using in forecasting. Note that when a statistical model is used to represent Biohaven Pharmaceutical stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 118.0073 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.6714 |
| MAPE | Mean absolute percentage error | 0.062 |
| SAE | Sum of the absolute errors | 40.9559 |
Predictive Modules for Biohaven Pharmaceutical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Biohaven Pharmaceutical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biohaven Pharmaceutical's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Biohaven Pharmaceutical After-Hype Price Prediction Density Analysis
As far as predicting the price of Biohaven Pharmaceutical at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Biohaven Pharmaceutical or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Biohaven Pharmaceutical, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Biohaven Pharmaceutical Estimiated After-Hype Price Volatility
In the context of predicting Biohaven Pharmaceutical's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Biohaven Pharmaceutical's historical news coverage. Biohaven Pharmaceutical's after-hype downside and upside margins for the prediction period are 5.79 and 21.19, respectively. We have considered Biohaven Pharmaceutical's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Biohaven Pharmaceutical is slightly risky at this time. Analysis and calculation of next after-hype price of Biohaven Pharmaceutical is based on 3 months time horizon.
Biohaven Pharmaceutical Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Biohaven Pharmaceutical is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biohaven Pharmaceutical backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Biohaven Pharmaceutical, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.07 | 7.70 | 0.02 | 0.03 | 10 Events / Month | 8 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
13.51 | 13.49 | 0.15 |
|
Biohaven Pharmaceutical Hype Timeline
Biohaven Pharmaceutical is currently traded for 13.51. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of -0.03. Biohaven is anticipated to decline in value after the next headline, with the price expected to drop to 13.49. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -0.15%, whereas the daily expected return is currently at -0.07%. The volatility of related hype on Biohaven Pharmaceutical is about 1590.91%, with the expected price after the next announcement by competition of 13.48. About 65.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 7.52. Biohaven Pharmaceutical had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days. Check out Historical Fundamental Analysis of Biohaven Pharmaceutical to cross-verify your projections.Biohaven Pharmaceutical Related Hype Analysis
Having access to credible news sources related to Biohaven Pharmaceutical's direct competition is more important than ever and may enhance your ability to predict Biohaven Pharmaceutical's future price movements. Getting to know how Biohaven Pharmaceutical's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Biohaven Pharmaceutical may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NTLA | Intellia Therapeutics | (1.20) | 10 per month | 0.00 | (0.09) | 10.12 | (8.86) | 47.56 | |
| IMNM | Immunome | (0.17) | 8 per month | 3.90 | 0.15 | 7.87 | (5.33) | 31.45 | |
| ABCL | Abcellera Biologics | 0.09 | 6 per month | 0.00 | (0.11) | 5.90 | (8.62) | 19.23 | |
| VERA | Vera Therapeutics | (0.55) | 14 per month | 3.13 | 0.15 | 10.77 | (5.81) | 23.44 | |
| ZBIO | Zenas BioPharma Common | (0.55) | 10 per month | 11.22 | 0.01 | 13.19 | (8.49) | 84.91 | |
| CLDX | Celldex Therapeutics | (0.81) | 8 per month | 0.00 | (0.04) | 6.44 | (5.22) | 13.96 | |
| PHVS | Pharvaris BV | 0.06 | 6 per month | 3.31 | 0.06 | 6.58 | (6.01) | 27.81 | |
| XERS | Xeris Pharmaceuticals | (0.19) | 28 per month | 0.00 | (0.08) | 4.71 | (4.35) | 26.11 | |
| SION | Sionna Therapeutics Common | (1.33) | 7 per month | 4.48 | 0.08 | 11.87 | (8.47) | 47.28 | |
| IMCR | Immunocore Holdings | (0.19) | 27 per month | 2.32 | 0 | 4.75 | (3.58) | 10.85 |
Other Forecasting Options for Biohaven Pharmaceutical
For every potential investor in Biohaven, whether a beginner or expert, Biohaven Pharmaceutical's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Biohaven Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Biohaven. Basic forecasting techniques help filter out the noise by identifying Biohaven Pharmaceutical's price trends.Biohaven Pharmaceutical Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Biohaven Pharmaceutical stock to make a market-neutral strategy. Peer analysis of Biohaven Pharmaceutical could also be used in its relative valuation, which is a method of valuing Biohaven Pharmaceutical by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Biohaven Pharmaceutical Market Strength Events
Market strength indicators help investors to evaluate how Biohaven Pharmaceutical stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Biohaven Pharmaceutical shares will generate the highest return on investment. By undertsting and applying Biohaven Pharmaceutical stock market strength indicators, traders can identify Biohaven Pharmaceutical Holding entry and exit signals to maximize returns.
Biohaven Pharmaceutical Risk Indicators
The analysis of Biohaven Pharmaceutical's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Biohaven Pharmaceutical's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting biohaven stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.66 | |||
| Standard Deviation | 7.54 | |||
| Variance | 56.83 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Biohaven Pharmaceutical
The number of cover stories for Biohaven Pharmaceutical depends on current market conditions and Biohaven Pharmaceutical's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Biohaven Pharmaceutical is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Biohaven Pharmaceutical's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Biohaven Pharmaceutical Short Properties
Biohaven Pharmaceutical's future price predictability will typically decrease when Biohaven Pharmaceutical's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Biohaven Pharmaceutical Holding often depends not only on the future outlook of the potential Biohaven Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Biohaven Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 91.2 M | |
| Cash And Short Term Investments | 486 M |
Check out Historical Fundamental Analysis of Biohaven Pharmaceutical to cross-verify your projections. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biohaven Pharmaceutical. If investors know Biohaven will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biohaven Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Biohaven Pharmaceutical is measured differently than its book value, which is the value of Biohaven that is recorded on the company's balance sheet. Investors also form their own opinion of Biohaven Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Biohaven Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biohaven Pharmaceutical's market value can be influenced by many factors that don't directly affect Biohaven Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biohaven Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Biohaven Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biohaven Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.